BRIEF published on 04/30/2025 at 07:35, 1 year 4 months ago Befesa SA annonce de solides performances au premier trimestre 2025 Efficacité Opérationnelle Augmentation Du Bénéfice Net Expansion Du Marché Prévisions Financières 2025 Résultats Du Premier Trimestre 2025
BRIEF published on 04/30/2025 at 07:35, 1 year 4 months ago AIXTRON Reports Strong Q1 Amidst Challenging Market Revenue Guidance Innovation Center Free Cash Flow Improvement AIXTRON Q1 2025 Photonics Market Growth
BRIEF published on 04/30/2025 at 07:35, 1 year 4 months ago AIXTRON annonce un premier trimestre solide dans un marché difficile Centre D'innovation Orientation Des Recettes AIXTRON T1 2025 Croissance Du Marché De La Photonique Amélioration Du Flux De Trésorerie Disponible
BRIEF published on 04/30/2025 at 07:35, 1 year 4 months ago Baader Bank Doubles Earnings in Q1 2025 Investment Strategy Baader Bank Financial Growth Q1 2025 Earnings Trading Revenue
BRIEF published on 04/30/2025 at 07:35, 1 year 4 months ago La Baader Bank double ses bénéfices au premier trimestre 2025 Croissance Financière Stratégie D'investissement Banque Baader Résultats Du Premier Trimestre 2025 Revenus Commerciaux
BRIEF published on 04/30/2025 at 07:35, 1 year 4 months ago Nicox Reports Full Year 2024 Financials Net Loss Cash Reserves Nicox Financial Results VYZULTA Revenue Sale NCX 470 Trials
BRIEF published on 04/30/2025 at 07:35, 1 year 4 months ago Nicox publie ses résultats financiers pour l'année 2024 Perte Nette Réserves De Trésorerie Résultats Financiers De Nicox Vente De Revenus De VYZULTA Essais NCX 470
BRIEF published on 04/30/2025 at 07:35, 1 year 4 months ago OSE Immunotherapeutics Presents New Gene Expression Signature at AACR 2025 Immuno-oncology Personalized Treatment Immune Checkpoint Blockade Gene Expression Signature Cancer Prediction
BRIEF published on 04/30/2025 at 07:35, 1 year 4 months ago OSE Immunotherapeutics présente une nouvelle signature d'expression génique à l'AACR 2025 Immuno-oncologie Blocage Du Point De Contrôle Immunitaire Signature D'expression Génétique Traitement Personnalisé Prédiction Du Cancer
BRIEF published on 04/30/2025 at 07:35, 1 year 4 months ago ALD Reports Solid First Quarter 2025 Financial Performance and Integration Progress Financial Results Revenue Growth Market Position Integration Progress Quarter 1 2025
Published on 09/08/2026 at 01:45, 3 hours 6 minutes ago Tunkillia Environmental Scoping Report Approved
Published on 09/05/2026 at 04:05, 3 days ago Pelican AI Corp. Announces Proposed Share Issuances and Litigation Update
Published on 09/04/2026 at 23:30, 3 days 5 hours ago FutureGen Industries Announces Shares for Debt Settlement
Published on 09/04/2026 at 23:00, 3 days 5 hours ago Golden Minerals Announces Management Change and Argentine Project Update
Published on 09/04/2026 at 22:30, 3 days 6 hours ago Panther Minerals Closes Brokered Private Placement of $3,000,000
Published on 09/07/2026 at 19:19, 9 hours 32 minutes ago EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Sales and Adjusted EBIT in Q2 2026/27 above prior-year level – FY outlook maintained
Published on 09/07/2026 at 19:00, 9 hours 51 minutes ago PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 31 août 2026 au 4 septembre 2026
Published on 09/07/2026 at 18:42, 10 hours 9 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 09/07/2026 at 18:00, 10 hours 51 minutes ago E-PANGO: e-Pango organise un webinaire avec ses actionnaires
Published on 09/07/2026 at 17:45, 11 hours 6 minutes ago VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Published on 09/07/2026 at 19:00, 9 hours 51 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 4 septembre 2026
Published on 09/07/2026 at 19:00, 9 hours 51 minutes ago Information concerning the total number of voting rights and shares in the share capital as of September 4, 2026
Published on 09/07/2026 at 18:05, 10 hours 46 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/08/2026
Published on 09/07/2026 at 18:05, 10 hours 46 minutes ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/08/2026
